SCHEMBL3266396

SCHEMBL3266396

C=CCOC(=O)Cc1ccccc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CA2 P00918 5/20 0.38
CA5A P35218 2/20 0.38
LIG1 P18858 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA9 Q16790 3/20 0.38
RHOA P61586 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
GPR52 Q9Y2T5 1/20 0.37
PARP10 Q53GL7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28030373 0.88 CYP3A4 (0.56) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL6404376 0.88 CYP3A4 (0.42) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL7113446 0.84 CYP3A4 (0.49) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL31290664 0.82 CYP3A4 (0.50) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL878244 0.81 CYP3A4 (0.49) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL8973261 0.81 ALDH1A1 (0.58) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL11128484 0.79 CYP3A4 (0.47) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL6032361 0.78 L3MBTL1 (0.47) CYP3A4NPSR1SMN1; SMN2TSHRKDM4E
SCHEMBL28521498 0.78 TDP1 (0.54) CYP3A4NPSR1PKMSMN1; SMN2ALDH1A1
SCHEMBL852520 0.78 PKM (0.53) PKMSMN1; SMN2ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099776-B1 CHELATING AGENT UNIV MUENCHEN TECH (DE) 2015-10-07 EP disclosed
US-20100081799-A1 Chelating Agent TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2010-04-01 US disclosed
EP-2099776-A1 CHELATING AGENT Technische Universität München (DE) 2009-09-16 EP disclosed
WO-2008068516-A1 CHELATING AGENT Technische Universität München (DE) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081799-A1 Chelating Agent HRH3, C3AR1, H1-3 CYP3A4 2762/4885NPSR1 1170/4885PKM 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.